Ascent Biomedical Ventures NY II Overview
- Fund Strategy
-
Venture
- Fund Status
-
Fully Invested
- Fund Manager
- Ascent Biomedica...
- Size
-
- Vintage
-
2008
- Dry Powder
-
Ascent Biomedical Ventures NY II General Information
Description
Ascent Biomedical Ventures NY II is an early-stage venture capital fund managed by Ascent Biomedical Ventures. The fund is located in New York, New York.
Contact Information
Fund Manager's Location
- 1 Rockefeller Plaza
- Suite 1040
- New York, NY 10020
- United States
Ascent Biomedical Ventures NY II Investments (9)
Ascent Biomedical Ventures NY II has made a total of 9 investments. Its most recent deal was a with Curaseal for . The deal was made on 01-May-2015.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Curaseal | 01-May-2015 | Therapeutic Devices | Generating Revenue | |||
| PQ Bypass | 22-Apr-2015 | Surgical Devices | Generating Revenue | |||
| Xlumena | 03-Dec-2013 | Therapeutic Devices | Startup | |||
| SpineView | 21-Oct-2011 | Surgical Devices | Startup | |||
| Cara Therapeutics | 21-Jul-2010 | Drug Discovery | Generating Revenue | |||
| Ancora Heart | 28-Apr-2010 | Therapeutic Devices | Clinical Trials - Phase 2 | |||
| Arstasis | 24-Apr-2009 | Surgical Devices | Startup | |||
| Targanox | 30-Mar-2009 | Early Stage VC (Series A) | Drug Discovery | Startup | ||
| Azevan Pharmaceuticals | 10-Mar-2009 | Later Stage VC (Series B) | Drug Discovery | Clinical Trials - Phase 2 |
Ascent Biomedical Ventures NY II Investment Strategy
Ascent Biomedical Ventures NY II Limited Partners (1)
New York State Common Retirement Fund is the sole limited partner of Ascent Biomedical Ventures NY II. Its latest Original was on 14-Oct-2008.
| Limited Partner Name | Type | Status | Commitment | Date | Commitment Type |
|---|---|---|---|---|---|
| New York State Common Retirement Fund | Current | 14-Oct-2008 | Original |
Ascent Biomedical Ventures NY II Returns Data
The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.
Ascent Biomedical Ventures NY II Returns History
| Period | Contribution (by all LPs) | Dry Powder | Distribution (to all LPs) | NAV | Total Fund Distr+NAV | IRR | DPI | RVPI | TVPI | Dry Powder % |
|---|
Ascent Biomedical Ventures NY II Benchmark (166)
| Fund Name | Fund Type | Vintage | IRR | Quartile | As of Date |
|---|---|---|---|---|---|
| Vertical Fund II | |||||
| Rocket Venture Fund | 31-Oct-2020 | ||||
| Rittenhouse Ventures I | 31-Dec-2024 | ||||
| Silver Creek Ventures III | 31-Dec-2013 | ||||
| Montreux Equity Partners I | |||||
| Bluestem Select Opportunities Fund | |||||
| Venrock Healthcare Capital Partners | |||||
| Stuart Mill Venture Partners Fund | |||||
| iNetworks BioOpportunity Fund | |||||
| Hatteras Venture Partners III | 31-Dec-2025 |
Ascent Biomedical Ventures NY II FAQs
-
What is Ascent Biomedical Ventures NY II?
Ascent Biomedical Ventures NY II is an early-stage venture capital fund managed by Ascent Biomedical Ventures.
-
Who manages Ascent Biomedical Ventures NY II?
Ascent Biomedical Ventures NY II is managed by Ascent Biomedical Ventures.
-
Where is Ascent Biomedical Ventures NY II domiciled?
Ascent Biomedical Ventures NY II is domiciled in United States: Delaware.
-
What is Ascent Biomedical Ventures NY II's size?
Ascent Biomedical Ventures NY II has a size of .
-
What type of fund is Ascent Biomedical Ventures NY II?
The fund type of Ascent Biomedical Ventures NY II is Venture.
-
What is the status of Ascent Biomedical Ventures NY II?
Ascent Biomedical Ventures NY II is fully invested.
-
What has Ascent Biomedical Ventures NY II invested in?
Ascent Biomedical Ventures NY II has made numerous investments in companies like Curaseal, PQ Bypass, and Xlumena within the Therapeutic Devices and Surgical Devices industries.
-
What has Ascent Biomedical Ventures NY II invested in recently?
Ascent Biomedical Ventures NY II's latest investment was on 01-May-2015 in Curaseal, a company within the Therapeutic Devices industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process